Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Morgan Stanley lowered the firm’s price target on Demant (WILYY) to DKK 345 from DKK 360 and keeps an Overweight rating on the shares.Maximize ...

In a report released today, Barry Jonas from Truist Financial maintained a Buy rating on DraftKings (DKNG – Research Report). The company’s ...

Q4 2024. Management View. Danske Bank reported a net profit of DKK 23.6 billion for 2024, exceeding its guidance range of DKK ...

Pandora A/S The Board of Directors has decided to launch a new share buy-back programme under which Pandora will buy back own shares for a maximum consideration of DKK 4.0 billion in the period ...

Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not offer financial advice, advisory or brokerage services, nor do we ...

The Board of Directors has decided to launch a new share buy-back programme under which Pandora will buy back own shares for a maximum consideration of DKK 4.0 billion in the period from 6 February ...

Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not offer financial advice, advisory or brokerage services, nor do we ...

(The company has denied the allegations.) Patel’s financial disclosure revealed he owns between one and five million dollars in Elite Depot Ltd. stock. Elite Depot is the ultimate controlling ...